{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:55:23Z","timestamp":1781585723396,"version":"3.54.5"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lipid storage myopathy (LSM) is characterized by abnormal lipid accumulation in skeletal muscle. Emerging evidence suggests that environmental factors, including the use of antidepressants such as sertraline, may trigger LSM. Given the established link between hyperhomocysteinemia (HHcy) and disrupted lipid metabolism, we investigated its potential role in skeletal muscle lipid deposition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled six patients with HHcy undergoing muscle biopsy and explored their clinical and pathological characteristics of skeletal muscle. The mechanistic link was explored in muscle tissues from patients through transcriptomic profiling, quantitative real-time polymerase chain reaction (qRT-PCR), western blotting, and enzymatic assays, and validated in C2C12 myotubes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four of the six patients presented with clinical myopathic manifestations, including progressive muscle weakness and exercise intolerance, which resolved completely after B-vitamin supplementation, while abnormal skeletal muscle lipid deposition was observed in all six patients. Transcriptome and qRT-PCR analyses demonstrated a significant upregulation of the acetyl-CoA carboxylase \u03b2 (\n                      <jats:italic>ACACB<\/jats:italic>\n                      ) gene (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), which encodes acetyl-CoA carboxylase 2 (ACC2), in the muscle tissues from patients. Furthermore, ACC2 protein expression was markedly elevated (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.01), thereby raising cellular malonyl-CoA levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.01). This metabolite potently inhibits carnitine palmitoyltransferase 1 (CPT1), impairing fatty acid oxidative metabolism in skeletal muscle. The key molecular cascade involving\n                      <jats:italic>ACACB<\/jats:italic>\n                      upregulation and subsequent CPT1 inhibition (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05), was further verified in C2C12 myotubes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study indicates that HHcy is closely associated with abnormal skeletal muscle lipid deposition. HHcy may correlate with increased ACC2 expression, which elevates malonyl-CoA levels. This, in turn, suppresses CPT1 activity and facilitates abnormal lipid accumulation in skeletal muscle.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1861632","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:29:41Z","timestamp":1781584181000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperhomocysteinemia promotes lipid deposition in skeletal muscle"],"prefix":"10.3389","volume":"17","author":[{"given":"Menghan","family":"Su","sequence":"first","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Hospital, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Research Center for Neurological Diseases, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11910-010-0154-y","article-title":"Lipid storage myopathy","volume":"11","author":"Liang","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00401-024-02830-x","article-title":"Lipid storage myopathy associated with sertraline treatment is an acquired mitochondrial disorder with respiratory chain deficiency","volume":"148","author":"Hedberg-Oldfors","year":"2024","journal-title":"Acta Neuropathol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1756286419843359","DOI":"10.1177\/1756286419843359","article-title":"Metabolic lipid muscle disorders: biomarkers and treatment","volume":"12","author":"Angelini","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ana.27030","article-title":"Multiple acyl-coenzyme a dehydrogenase deficiency is associated with sertraline use\u2014is there an acquired form?","volume":"96","author":"Sunebo","year":"2024","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/alz.12871","article-title":"Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: new evidence, potential therapeutic strategies, and biomarkers","volume":"19","author":"Carey","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2457527","DOI":"10.1080\/07853890.2025.2457527","article-title":"Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside","volume":"57","author":"Tian","year":"2025","journal-title":"Ann Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2024.10.014","article-title":"Hyperhomocysteinemia is linked to MASLD","volume":"131","author":"De Matteis","year":"2025","journal-title":"Eur J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ajcn\/nqac285","article-title":"Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation","volume":"116","author":"Yuan","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1419579","DOI":"10.3389\/fcvm.2024.1419579","article-title":"Association between homocysteine levels and hyperlipidemia prevalence as well as all-cause mortality of hyperlipidemia patients in the US population: results from NHANES database","volume":"11","author":"Wei","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3945\/jn.114.199711","article-title":"L-serine supplementation attenuates alcoholic fatty liver by enhancing homocysteine metabolism in mice and rats","volume":"145","author":"Sim","year":"2015","journal-title":"J Nutr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41392-024-01914-0","article-title":"Ribosomal modification protein rimK-like family member a activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis","volume":"9","author":"Yan","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e2415563","DOI":"10.1002\/advs.202415563","article-title":"Homocysteine promotes the pathogenesis of atherosclerosis through the Circ-PIAS1-5\/miR-219a-2-3p\/TEAD1 Axis","volume":"12","author":"Ma","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1177\/1535370218788520","article-title":"Nuclear factor erythroid 2-related factor 2 activation mediates hyperhomocysteinemia-associated lipolysis suppression in adipocytes","volume":"243","author":"Li","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1007\/s10072-020-04962-w","article-title":"A novel Q93H missense mutation in DCTN1 caused distal hereditary motor neuropathy type 7B and Perry syndrome from a Chinese family","volume":"42","author":"Zhang","year":"2021","journal-title":"Neurol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3988\/jcn.2023.0486","article-title":"CGG repeat expansion in NOTCH2NLC causing overlapping Oculopharyngodistal myopathy and neuronal Intranuclear inclusion disease with diffusion weighted imaging abnormality in the cerebellum","volume":"20","author":"Ma","year":"2024","journal-title":"J Clin Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"101540","DOI":"10.1016\/j.molmet.2022.101540","article-title":"A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression","volume":"63","author":"Xu","year":"2022","journal-title":"Mol Metab"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1073\/pnas.97.4.1444","article-title":"The subcellular localization of acetyl-CoA carboxylase 2","volume":"97","author":"Abu-Elheiga","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"100676","DOI":"10.1016\/j.jlr.2024.100676","article-title":"Targeting acetyl-CoA carboxylases for the treatment of MASLD","volume":"65","author":"Mateo-Mar\u00edn","year":"2024","journal-title":"J Lipid Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1016\/S0021-9258(18)68808-8","article-title":"Regulation of acetyl-coenzyme a carboxylase. II. Effect of fasting and refeeding on the activity, phosphate content, and aggregation state of the enzyme","volume":"263","author":"Thampy","year":"1988","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116","author":"Savage","year":"2006","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.plipres.2015.11.004","article-title":"Carnitine palmitoyltransferase 1C: From cognition to cancer","volume":"61","author":"Casals","year":"2016","journal-title":"Prog Lipid Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bbadis.2015.01.008","article-title":"Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications","volume":"1852","author":"Veeranki","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbadis.2014.06.031","article-title":"Spectrum of metabolic myopathies","volume":"1852","author":"Angelini","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.31083\/j.fbs1602012","article-title":"The multifaceted cause of lipid storage myopathies, genetics, and treatment","volume":"16","author":"Angelini","year":"2024","journal-title":"Front Biosci (Schol Ed)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"102430","DOI":"10.1016\/j.sbi.2022.102430","article-title":"DNA methylation: precise modulation of chromatin structure and dynamics","volume":"75","author":"Li","year":"2022","journal-title":"Curr Opin Struct Biol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/acschembio.0c00771","article-title":"Non-histone protein methylation: biological significance and bioengineering potential","volume":"16","author":"Di Blasi","year":"2021","journal-title":"ACS Chem Biol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.1074\/jbc.M117.809236","article-title":"Homocysteine regulates fatty acid and lipid metabolism in yeast","volume":"293","author":"Visram","year":"2018","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e4369","DOI":"10.1371\/journal.pone.0004369","article-title":"ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus","volume":"4","author":"Castle","year":"2009","journal-title":"PLoS One"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1861632\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:29:43Z","timestamp":1781584183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1861632\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":29,"alternative-id":["10.3389\/fneur.2026.1861632"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1861632","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"article-number":"1861632"}}